drugset
Drugs / neural progenitor cell
last change Dec 2017 re-read 3 minutes ago

neural progenitor cell

Cell therapy

Developed for
brain hypoxia - ischemia
Investigated by
252 Military Hospital · Bethune International Peace Hospital · Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Hunan Children's Hospital · Navy General Hospital, Beijing · Shangluo Central Hospital

Trials 1

today NCT02854579 · not/applicable
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT02854579 Jan 2013 → Jul 2017 brain hypoxia - ischemia Navy General Hospital, Beijing Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as neural progenitor cell ClinicalTrials.gov intervention name — accepted as the source's own label NCT02854579 ↗
Modality Cell therapy “allogenic neural progenitor cells transplantation” NCT02854579 ↗
Route Intrathecal “intrathecally” NCT02854579 ↗